| Inverness Medical Innovations to Attend the Jefferies 2010 Global Life Sciences Conference on June 8, 2010 (PR Newswire) Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Jefferies 2010 Global Life Sciences Conference being held June 8 through 11, 2010 at the Grand Hyatt, New York, New York. us.rd.yahoo.com |
BioClinica Unveils Platform for Integrated Clinical Operations Based on Microsoft Technologies (Business Wire) NEWTOWN, Pa.----BioClinicaâ„¢, Inc., , a global provider of clinical trial management services, will exhibit at the 46th Drug Information Association Annual Meeting from June 13-17, 2010 in Washington, D.C., where it will showcase the BioClinica eClinical Technology Suite as well as introduce the BioClinica Integrated Operations Platform . us.rd.yahoo.com |
Reports Cite Risks of Blood-Clot Devices The FDA and the Archives of Internal Medicine warn of problems associated with some devices used to keep blood clots from traveling to the lungs. online.wsj.com |
Minnesota Balks at Health-Law Funds Gov. Pawlenty acted to block Minnesota from tapping some money, citing undue intrusion by the federal government into state and private affairs. online.wsj.com |
4 Biotech Growth Stocks at a Reasonable Price Benzinga submits: By Scott RubinA screen of biotechnology stocks focusing on strong revenue growth and reasonable valuations turned up some interesting, and widely followed, names. The metrics the screen used were Nasdaq and NYSE companies in the drugs and biotechnology sector that had a market capitalization over $1 billion, revenue growth between 15-25% year over year, a P/E ratio less than 20 and a PEG ratio less than 2.Complete Story » seekingalpha.com |